Open the NEPSE sector page, and you will see two insurance groups sitting side by side: Life Insurance and Non-Life Insurance. Most retail traders treat them as one bucket. They screen “insurance,” buy whatever is cheap, and hold. That is the mistake this article is about. When you compare life vs non-life insurance on NEPSE, you are not comparing two flavors of the same thing. You are comparing two businesses that happen to share a word in their names and almost nothing else.
A life insurer is, underneath the marketing, a long-duration savings and investment machine. A non-life (general) insurer is a short-tail underwriting shop that prices risk for a year at a time. They earn money differently, they blow up differently, and they suit different investors. If you cannot say which one you own and why, you are guessing.
This piece is the comparison. It does not re-derive the full analytical toolkit. For premiums, claims, the combined ratio, and float defined properly, read our companion guide on how to analyze an insurance stock on NEPSE. Here we assume you know the vocabulary and want the verdict.
Two businesses, one sector label
Start with the number of names you are choosing between. As of 2026, Nepal has roughly 14 life insurers and 14 non-life insurers in operation, most of them listed on NEPSE. That near-symmetry is recent and deliberate. The regulator forced it.
The Nepal Insurance Authority (NIA) raised the minimum paid-up capital to NPR 5 arba for life insurers and NPR 2.5 arba for non-life insurers, then pushed the sector into mergers to get there. The count of insurers collapsed. Prime Life, Union Life and Gurans Life combined into one entity. Himalayan Life emerged from a merger with paid-up capital reported around NPR 7 arba. If you want the investor angle on what these deals do to your shares, we covered it separately in insurance mergers on NEPSE.
The point for now is simpler. The regulator treats life and non-life as separate license classes with separate capital rules for a reason. They are separate businesses. So should you.
How a life insurer actually makes money
A life policy in Nepal is rarely pure protection. Most of what sells is endowment: a savings product with a death benefit stapled on. The customer pays a premium every year for 15, 20, or 25 years. The insurer promises a lump sum at maturity, plus bonuses, plus a payout if the policyholder dies first.
That structure does two things that matter to you as a shareholder.
First, it builds an enormous pool of money the insurer holds for decades before it has to pay anything back. This is the insurance fund, the life-insurance version of float. The scale is hard to overstate. The industry’s total life insurance fund runs into the hundreds of billions of rupees, with a single company like Nepal Life reported holding an insurance fund above NPR 200 arba. The insurer invests that pool, mostly in fixed deposits, government bonds, and equities, and the spread between what it earns and what it owes policyholders is where a large slice of profit comes from. A life insurer is, in plain terms, an asset manager wearing an insurance license.
Second, the liabilities are long and estimated, not known. How much the insurer must eventually pay depends on mortality assumptions, lapse rates, bonus declarations, and the discount rate applied to future payouts. This is actuarial reserving, and it dominates the accounts. Reported profit in a life company is heavily an accounting judgment about reserves, not a simple cash figure. That is why life-insurer earnings look smooth and why a policy sold this year does not fully show up in profit for years.
The result is a slow, sticky, compounding business. Policies renew for decades. Premium growth is steady rather than dramatic. In the third quarter of FY 2081/82, the life sector grew premiums by around 15% year on year and posted collective net profit growth near 12%. Nothing exciting quarter to quarter. Value builds over a very long horizon.
How a non-life insurer actually makes money
Now flip to general insurance: motor, fire, marine, engineering, health, and crop. The typical policy lasts one year. The customer pays a premium, and within twelve months either something is claimed or it is not. Then the contract ends and gets repriced.
Because the tail is short, the whole business lives or dies on underwriting. Did you price the risk correctly this year? The single number that answers that is the combined ratio, claims plus expenses as a percentage of premium earned. Below 100, the underwriting itself made money, and the float is effectively free. Above 100, you are paying to hold the float, and your investment book has to dig you back out before shareholders see a real return. That mechanism is spelled out in the analysis framework; the takeaway here is that for a non-life insurer it is the whole game.
Non-life insurers hold float too. Industry investments run roughly in line with equity, close to a one-to-one ratio, with sector investments reported around NPR 72 arba against a similar equity base. But the float is smaller and shorter than a life insurer’s, so it cannot carry the company on its own. Underwriting has to work.
And then there is the thing that makes non-life fundamentally lumpier: catastrophe. Nepal sits on top of earthquake, flood, and landslide risk, and international reinsurers price the country as high-risk territory. A quiet year produces a clean combined ratio and a happy annual report. A bad year, an earthquake, and a flood season wipe out several years of underwriting profit in a single quarter. After the 2025 earthquake, non-life premium collection reportedly jumped around 28% as demand spiked, but loss ratios and future reinsurance costs rose with it. That is the non-life pattern in one sentence: results are jagged, and the disaster you cannot predict is the one that sets the price.
The risk profiles are opposite, not similar
Put the two side by side, and the risks barely overlap.
A life insurer’s biggest risks are financial and actuarial. If interest rates on fixed deposits fall for years, the spread on that giant investment fund shrinks and the guarantees embedded in old policies start to bite. If the equity market it invested in corrects hard, reported profit and solvency both wobble. If reserving assumptions were too optimistic, the pain arrives slowly and quietly over years. Life insurance risk is the risk of a long, grinding mismatch between what you promised decades ago and what you can earn today.
A non-life insurer’s biggest risk is a single event. One earthquake changes everything at once. Its exposure is concentrated, correlated, and sudden, which is exactly why reinsurance matters so much and why the NIA restricts how much of its net worth an insurer can retain on a single risk. A non-life insurer without solid treaties with rated international reinsurers is one bad season from a solvency problem.
This is where the NIA’s newer Risk-Based Capital and Solvency Directive comes in. It moves both classes away from a flat capital number toward capital sized to each company’s actual risk profile, with restrictions on dividend distribution for insurers that fall below solvency thresholds. For you, that regime rewards different behavior in each class. For life insurers, watch asset quality and reserving. For non-life, watch catastrophe coverage and the combined ratio. The solvency ratio is worth understanding in detail before you buy either; we break it down in insurance solvency ratio in Nepal.
What to watch, class by class
If you own or are eyeing a life insurer, track these:
- Insurance fund growth and the yield the company earns on it. This is the engine.
- Net premium and renewal (persistency) trends. Lapsing policies quietly destroy the model.
- Reserving and actuarial assumptions and any change to the discount rate or bonus rate. Buried in the notes, but it moves the profit more than any headline.
- Investment mix. A life fund overweight in equities will report volatile profit; overweight fixed deposits will suffer when rates fall.
If you own or are eyeing a non-life insurer, track these:
- The combined ratio, quarter by quarter and across a full cycle. One clean year proves nothing.
- Reinsurance arrangements and net retention. Who is behind the company when the earthquake comes?
- Claims mix and any concentration (a book heavy in one region or one catastrophe-prone line).
- Investment income as a share of profit. If underwriting keeps losing and only the investment book keeps the lights on, that is a warning, not a strength.
Notice how little these two lists share. That is the whole argument.
The verdict: which model wins on NEPSE today
Here is our position, stated plainly. For a long-horizon investor buying quality and holding, the life model is the more attractive of the two on NEPSE today, and it is not especially close.
The reasoning is structural. Life insurance in Nepal has low penetration and a young population still moving into formal savings products, which gives the strongest life franchises a long, predictable runway. The business compounds a growing insurance fund for decades, and the leaders already show it: Nepal Life reported the sector’s highest individual profit and by far the largest insurance fund. Earnings are smoother, the model is stickier, and the main risks (rates and reserving) are slow-moving and readable if you do the work. You are buying a compounding machine and paying for patience.
Non-life, by contrast, asks you to underwrite a catastrophe you cannot time. In a benign year, the combined ratios look wonderful, and the stocks get chased. Then a flood season or an earthquake arrives, and the same names give back years of gains at once. You can absolutely make money in non-life, but you are being paid to carry tail risk, and most NEPSE retail buyers hold these stocks without pricing that tail at all. That is speculation dressed as sector investing.
Now the opposing case, because it is real. Life insurers are opaque. Reserving is a judgment you largely have to trust management and the actuary on, and a life fund heavy in equities can turn a “boring” holding into a volatile one when NEPSE corrects. Their profit is more accounting than cash. Non-life, for all its lumpiness, is more transparent: the combined ratio is a hard, checkable number, and a disciplined general insurer that consistently underwrites below 100 and reinsures properly is a genuinely high-quality business that can outperform a mediocre life insurer with a bloated fund and thin margins. Quality of the individual company beats the sector label every time. A well-run non-life insurer is a better holding than a poorly run life insurer.
That caveat matters, but it does not change the base case. Averaged across the two books as they trade on NEPSE, and for the typical investor who is not going to read every reinsurance treaty, the life model offers the better risk-adjusted proposition: slower, but far more predictable, with a structural growth story behind it. Non-life is the traders’ vehicle, the place for people who understand they are being paid to hold a bomb that may not go off.
Match the model to yourself. If you want to hold for a decade and sleep at night, favor a strong life insurer. If you trade cycles and can stomach a quarter that erases a year, non-life will give you the swings you are looking for. What you should not do is buy “insurance,” lump the two together, and pretend the sector page is telling you what you own. It is not. And do not confuse a large paid-up capital with a large, well-invested fund; they are different things, as we explain in market cap vs. paid-up capital.
This is analysis, not financial advice.
